A RANDOMIZED, DOUBLE-MASKED CONTROLLED CLINICAL TRIAL OF SANDOSTATIN LONG-ACTING RELEASE DEPOT IN PATIENTS WITH POSTSURGICAL CYSTOID MACULAR EDEMA
Explore this paper's citation graph
Summary
Although there were no statistically significant differences between both groups in retinal thickening or angiographic leakage, octreotide-treated patients were more likely to experience a ≥2-line improvement in visual acuity.
- Type
- article
- Published
- 2010-01-01
- Cited by
- 12
- References
- 48
- OpenAlex
- https://openalex.org/W2012467538
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:13725471
Keywords
Medicine, Macular edema, Octreotide, Visual acuity, Placebo
References
- Medical prophylaxis and treatment of cystoid macular edema after cataract surgery. The results of a meta-analysis.
- Cystoid macular edema in retinitis pigmentosa.
- Chronic cystoid macular edema and predictors of visual acuity.
- Age and topographic variation of insulin-like growth factor-binding protein 2 in the human rpe.
- Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor
- Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease.
- Medical treatment of macular edema in patients with uveitis
- Localization, chromatographic characterization, and development of somatostatin-like immunoreactivity in the guinea pig retina
- Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report.
- Somatostatin-like immunoreactive material in associational ganglion cells of human retina.
- Somatostatin inhibits IGF-1 mediated induction of VEGF in human retinal pigment epithelial cells.
- Immunoreactive and biologically active somatostatin-like material in the human retina.
- Somatostatin-like immunoreactive material in the rabbit retina.
- Somatostatin inhibits the production of vascular endothelial growth factor in human glioma cells
- Supplemental oxygen improves diabetic macular edema: a pilot study.
- Immunoreactive and biologically active somatostatin-like material in rat retina.
- Inhibition of IGF-I and b-FGF stimulated growth of human retinal endothelial cells by the somatostatin analogue, octreotide: a potential treatment for ocular neovascularization.
- Octreotide reduces vitreous hemorrhage and loss of visual acuity risk in patients with high-risk proliferative diabetic retinopathy.
- Sandostatin LAR for cystoid diabetic macular edema: a 1-year experience.
- Treatment of cystoid macular edema with octreotide.
Cited by
- Protective role of somatostatin receptor 2 against retinal degeneration in response to hypoxia
- Vitreous levels of somatostatin in patients with chronic uveitic macular oedema
- Silicon Micro- and Nanofabrication for Medicine
- Profilaxia e tratamento do edema macular cistoide após cirurgia de catarata Prophylaxis and treatment of cystoid macular edema after cataract surgery
- Current Advances in Pharmacotherapy and Technology for Diabetic Retinopathy: A Systematic Review
- Spermine oxidase: A Promising Therapeutic Target for Neurodegeneration in Diabetic Retinopathy
- Visual impairment in high flow and low flow carotid cavernous fistula
- Simple surgical punctal occlusion with high frequency radiowave electrosurgery
- Current management options for the treatment of refractory postoperative cystoid macular Edema: A systematic review.
- Somatostatin analogues as a treatment option for cystoid maculopathy in retinitis pigmentosa
- Molecular and cellular mechanisms underlying gyrate atrophy: Why is the retina primarily affected?
- Pathologie, Klinik und Behandlung von diabetischen retinalen Gefäßerkrankungen
Related papers
- Clinical Studies of Octreotide Treatment of Acute Pancreatitis
- Clinical Value of Monitoring Plasma Octreotide Levels During Chronic Octreotide Long-Acting Repeatable Therapy in Carcinoid Patients
- Role of Prophylactic Octreotide in Pancreaticoduodenectomy: A Single Centre Comparative Study in 456 Whipple's Patients
- Octreotide inhibits pancreatic exocrine secretion and prevents pancreatoenterostomy leakage.
- Effect of Octreotide LAR Dose and Weight on Octreotide Blood Levels in Patients With Neuroendocrine Tumors
- Clinical use of the long acting somatostatin analogue octreotide in pediatrics
- Clinical use of the long acting somatostatin analogue octreotide in pediatrics
- Is Octreotide Treatment Useful in Patients with Congenital Chylothorax?
- Patient's Self-recognition of Reduced Visual Acuity Due to Recurrence of Macular Edema and Prompt Visitation to the Hospital in Retinal Vein Occlusion
- Potential Acuity Meter and Visual Outcome in Pseudophakic Eyes with Clinical Cystoid Macular Edema